80% of Tuberculosis Patients Don’t Have Persistent Cough
A study of more than 600,000 individuals shows that 4 in 5 with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
A study of more than 600,000 individuals shows that 4 in 5 with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
Merck’s investigational drug for chronic cough is one step closer to coming to market after receiving a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use.
New research found that gefapixant is associated with a significant reduction in cough frequency in people with unexplained chronic cough.
Researchers have invented a portable surveillance device powered by machine learning which can detect coughing and crowd size in real time.
Read MoreAn experimental drug called gefapixant blocks a cellular receptor that’s key to the cough reflex, according to research published in The Lancet Respiratory Medicine.
Read MoreA 34-year-old ESPN reporter is dead after battling pneumonia, according to several news reports.
Read MoreFeNO may be useful for diagnosing cough variant asthma in patients with chronic cough who have normal spirometry.
Read MoreRespivant Sciences has dosed the first patient in the SCENIC trial, a Phase 2b study of RVT-1601 for the treatment of persistent cough in patients with idiopathic pulmonary fibrosis (IPF).
Read MoreA study published in Clinical Infectious Diseases found that US cases of pertussis have risen significantly since 2000.
Read MoreVisitors to Zion National Park are being asked to monitor pneumonia in the park’s bighorn sheep by reporting their coughing.
Read MoreBoth subjective and objective evidence of laryngeal dysfunction may be common in individuals with chronic cough and cough hypersensitivity syndrome (CHS), according to a study published in the Journal of Allergy and Clinical...
Read MoreLevels of fractionated exhaled of nitric oxide (FeNO) can indicate whether patients with unexplained coughs need treatment with inhaled corticosteroids.
Read MoreAfferent Pharmaceuticals has announced the results of a Phase 2 clinical trial that showed the company’s drug candidate AF-219 reduced daytime cough frequency by 75%.
Read MoreOne study has shown that the common cholesterol-lowering drugs could provide relief to patients suffering from bronchiectasis, a chronic lung disease.
Read MorePulmonary rehabilitation and disease management offer strategies for patients to become actively involved in their care and improve their functional outcomes.
Read More